JP2024523495A5 - - Google Patents

Info

Publication number
JP2024523495A5
JP2024523495A5 JP2023579103A JP2023579103A JP2024523495A5 JP 2024523495 A5 JP2024523495 A5 JP 2024523495A5 JP 2023579103 A JP2023579103 A JP 2023579103A JP 2023579103 A JP2023579103 A JP 2023579103A JP 2024523495 A5 JP2024523495 A5 JP 2024523495A5
Authority
JP
Japan
Prior art keywords
use according
dosage form
hme
hpmc
printable material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023579103A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523495A (ja
Filing date
Publication date
Priority claimed from EP21305967.8A external-priority patent/EP4115878A1/en
Application filed filed Critical
Priority claimed from PCT/EP2022/069012 external-priority patent/WO2023281031A1/en
Publication of JP2024523495A publication Critical patent/JP2024523495A/ja
Publication of JP2024523495A5 publication Critical patent/JP2024523495A5/ja
Pending legal-status Critical Current

Links

JP2023579103A 2021-07-09 2022-07-07 デンプンベースの印刷可能な材料 Pending JP2024523495A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21305967.8 2021-07-09
EP21305967.8A EP4115878A1 (en) 2021-07-09 2021-07-09 Starch based printable materials
EP21209140.9 2021-11-18
EP21209140.9A EP4115877A1 (en) 2021-07-09 2021-11-18 Starch based printable materials
PCT/EP2022/069012 WO2023281031A1 (en) 2021-07-09 2022-07-07 Starch based printable materials

Publications (2)

Publication Number Publication Date
JP2024523495A JP2024523495A (ja) 2024-06-28
JP2024523495A5 true JP2024523495A5 (https=) 2025-04-17

Family

ID=82703190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023579103A Pending JP2024523495A (ja) 2021-07-09 2022-07-07 デンプンベースの印刷可能な材料

Country Status (6)

Country Link
US (1) US20240226016A1 (https=)
EP (1) EP4366706B1 (https=)
JP (1) JP2024523495A (https=)
KR (1) KR20240035438A (https=)
ES (1) ES3052859T3 (https=)
WO (1) WO2023281031A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL449954A1 (pl) * 2024-10-04 2026-04-07 Uniwersytet Przyrodniczy we Wrocławiu Sposób wytwarzania biodegradowalnego materiału do druku 3D w technologii SLS
PL449955A1 (pl) * 2024-10-04 2026-04-07 Uniwersytet Przyrodniczy we Wrocławiu Sposób wytwarzania biodegradowalnego materiału do druku 3D w technologii SLS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2966828B1 (fr) * 2010-11-02 2012-12-28 Roquette Freres Poudre de polysaccharide et de polyol, comprimable et de haute viscosite
CN116270513A (zh) * 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型

Similar Documents

Publication Publication Date Title
JP2024523495A5 (https=)
ES2202374T3 (es) Preparacion farmaceutica que contiene metformina y procedimiento para su fabricacion.
TWI262799B (en) Flash-melt oral dosage formulation
JP2024539891A5 (https=)
NO329926B1 (no) Farmasoytisk sammensetning og fremgangsmate for fremstilling derav
RS55174B1 (sr) Formulacija i metod obložene tablete
HU201469B (en) Process for producing orally administrable composition with osmotic dosing, comprising metoprolol salt
BRPI0714265A2 (pt) composiÇço oral sàlida, processo para preparar uma composiÇço oral sàlida, uso de uma composiÇço e mÉtodo para tratar hiv
HUT65756A (en) Controlled release compositions comprising extruded core and process for production of these compositions
JP2020523335A5 (https=)
HU226956B1 (en) Matrix tablet for sustained release of trimetazidine after oral administration
JP2022535893A5 (https=)
CZ20001659A3 (cs) Prostředek s prodlouľeným uvolňováním
UA126702C2 (uk) Фармацевтична композиція, яка містить брекспіпразол
WO2013057469A1 (en) Pharmaceutical antiretroviral compositions
RU2694056C2 (ru) Противотуберкулезная стабильная фармацевтическая композиция в форме диспергируемой таблетки, содержащей гранулированный изониазид и гранулированный рифапентин, и способ ее приготовления
CN114146089B (zh) 含依非韦伦、替诺福韦和恩曲他滨的药物组合物
CN104800184B (zh) 琥珀酸呋罗曲坦缓释剂片
EP2988735B1 (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
CN105407875A (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法
JP7276760B2 (ja) 4-アミノ-3-ブタン酸類縁体含有固形製剤
JP6618595B1 (ja) カフェインおよびヒヨスチアミン含有医薬組成物およびその製造方法
CN116019776A (zh) 一种治疗幽门螺旋杆菌感染的3d打印组合片及其制备方法
JP2024500545A5 (https=)
JP7352175B2 (ja) トルバプタン製剤